The gut microbiota–brain axis in neurological disorders

Citations Over TimeTop 1% of 2024 papers

Abstract

Previous studies have shown a bidirectional communication between human gut microbiota and the brain, known as the microbiota-gut-brain axis (MGBA). The MGBA influences the host's nervous system development, emotional regulation, and cognitive function through neurotransmitters, immune modulation, and metabolic pathways. Factors like diet, lifestyle, genetics, and environment shape the gut microbiota composition together. Most research have explored how gut microbiota regulates host physiology and its potential in preventing and treating neurological disorders. However, the individual heterogeneity of gut microbiota, strains playing a dominant role in neurological diseases, and the interactions of these microbial metabolites with the central/peripheral nervous systems still need exploration. This review summarizes the potential role of gut microbiota in driving neurodevelopmental disorders (autism spectrum disorder and attention deficit/hyperactivity disorder), neurodegenerative diseases (Alzheimer's and Parkinson's disease), and mood disorders (anxiety and depression) in recent years and discusses the current clinical and preclinical gut microbe-based interventions, including dietary intervention, probiotics, prebiotics, and fecal microbiota transplantation. It also puts forward the current insufficient research on gut microbiota in neurological disorders and provides a framework for further research on neurological disorders.

Related Papers

• → Gut Microbiota-brain Axis(2016)517 cited
• → Role of gut microbiota via the gut-liver-brain axis in digestive diseases(2020)168 cited
• → The role of gut microbiota in the gut-brain axis: current challenges and perspectives(2013)147 cited
• → Gut hormones in microbiota-gut-brain cross-talk(2020)134 cited
• → The potential of human milk oligosaccharides to impact the microbiota-gut-brain axis through modulation of the gut microbiota(2020)54 cited